Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Legacy Ventures Hawaii was a private company formed in 2019 to pursue opportunities in CBD hemp in Hawaii through investments in science, cultivation, extraction, and commercialization. The company became known primarily through its joint venture with Arcadia Biosciences, Archipelago Ventures Hawaii, which was created to grow, extract, and sell hemp and hemp-derived products using a vertically integrated seed-to-sale model. Legacy Ventures Hawaii contributed local market knowledge, extraction and sales experience, and relationships in Hawaii and Asian markets, while Arcadia contributed genetics expertise and cultivation capabilities. Available public information does not indicate a broader therapeutic drug-development pipeline or conventional biopharma R&D organization; rather, it appears to have operated at the intersection of hemp agriculture, extraction, and cannabinoid product commercialization. Corporate registry information indicates the Nevada entity was revoked on August 1, 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Legacy Ventures Hawaii.